Carcinoma  >>  ganitumab (AMG 479)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ganitumab (AMG 479) / Takeda, ImmunityBio
GAMMA, NCT01231347 / 2010-020398-18: QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Checkmark Data - Oct 2013
Oct 2013 - Oct 2013: Data - Oct 2013
Checkmark P3 data - ASCO
Jun 2012 - Jun 2012: P3 data - ASCO
Checkmark P3 data
More
Terminated
3
800
Japan, US, Canada, Europe, RoW
AMG 479, Placebo, gemcitabine, Gemzar
NantCell, Inc., Takeda
Adenocarcinoma of the Pancreas, Advanced Solid Tumors, Cancer, Cancer of Pancreas, Cancer of the Pancreas, Metastases, Metastatic Cancer, Metastatic Pancreatic Cancer, Pancreas Cancer, Pancreatic Cancer, Bone Metastases, Endocrine Cancer, Oncology, Oncology Patients, Solid Tumors, Advanced Malignancy
12/12
12/12

Download Options